Update on Indications, Interactions and Complications in the Use of Pharmaceuticals
Course
In Departs Honolulu (USA)
*Indicative price
Original amount in USD:
$ 695
Description
-
Type
Course
-
Location
Departs honolulu (USA)
-
Duration
7 Days
Suitable for: Pharmacists, Primary Care Physicians, Nurses, NPs, PAs
Facilities
Location
Start date
Start date
Reviews
Course programme
Course review:
After attending the following session individuals should be able to:
1. Outline strategies for assessing and counseling patients on the use of OTC products.
2. Describe patients attitude about monitoring and diagnostics for self-care.
3. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance.
4. Describe the mechanism of action and indications for newly approved drugs.
5. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
6. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
7. Describe the benefits and limitations of collaborative practice models in various patient care settings.
********************************************************************************
Patient’s Role in Self-Care: Working with Their Health Care Providers
1. Outline strategies for assessing and counseling patients on the use of OTC products.
Monitoring and Diagnostic Devices for Self-Care
2. Describe patients attitude about monitoring and diagnostics for self-care.
FDA and Regulatory Update on Pharmaceuticals
3. Explain issues related to drug safety, patient information, and other recent FDA activities such as prescription drug labeling, MedWatch, and post-marketing safety surveillance
New Product Approvals for 2011
4. Describe the mechanism of action and indications for newly approved drugs.
Medication Safety and Medication Errors in the Medication Use Process
5. Identify challenges and safety concerns regarding the medication approval and post-market surveillance processes.
Minimizing Medication Errors and Liability Through Technology
6. Describe the necessary points within the medication use system in which technology can be employed to reduce medical errors within health care.
Developing Collaborative Care Models
7. Describe the benefits and limitations of collaborative practice models in various patient care settings.
Conference Sessions generally take place during the days at sea (as cruise itinerary allows) to avoid conflicts with Ports of Call or evening entertainment.
Additional information
Update on Indications, Interactions and Complications in the Use of Pharmaceuticals
*Indicative price
Original amount in USD:
$ 695